There’s been a lot of controversy around the covid vaccines these days, and these seem to continue. Not too long ago, we revealed that Pfizer has been making headlines lately due to some issues that have been popping up around their vaccine.
Also, we addressed Pfizer’s experimental oral drug that treats Covid-19 at the very first sign that will be available by the end of this year, the company’s CEO said.
The other vaccines (Moderna, Johnson & Johnson, AstraZeneca) were surrounded by scandals as well, and this led people to become extremely confused regarding the vaccines against the novel coronavirus.
Second Pfizer covid shot news
Reuters just revealed the fact that “Pfizer’s (PFE.N) COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first,” a British study said.
It’s been reported that the study released on Friday is the first to directly compare immune responses of the Pfizer shot from the three-week dosing interval tested in clinical trials and the extended 12-week interval that British officials recommend in order to give more vulnerable people at least some protection quickly.
Pfizer said that there’s no data to back up this move.
“Our study demonstrates that peak antibody responses after the second Pfizer vaccine are markedly enhanced in older people when this is delayed to 12 weeks,” Helen Parry, an author of the study based at the University of Birmingham, said.
We suggest that you check out the complete report coming from Reuters.
WHO drops shocking statement
In other recent news, the WHO just released quite an unexpected statement about the pandemic.
The Guardian just noted that the covid pandemic was a preventable disaster that need not have cost millions of lives if the world had reacted more quickly.
Stay tuned for more news and stay safe.